Alaway and Nasal Congestion

This page shows results related to Alaway and Nasal Congestion from the FDA Adverse Event Reporting System (AERS). The adverse event Nasal Congestion has been reported to the FDA a total of 2 times for Alaway.

Learn More About Alaway Adverse Events

Safety Comparison of Nasal Congestion in Alaway and Related Drugs

The Proportional Reporting Ratio (PRR) for Alaway and Nasal Congestion is 4. The chart below compares this proportional reporting ratio of Nasal Congestion for drugs used in similar therapies to Alaway. The higher the proportional reporting ratio is, the more likely a drug is associated with Nasal Congestion.

Nasal Congestion

NOTE: The PRR metric is still in Beta testing by DrugCite and is intended for use by researchers only.

People Reporting Nasal Congestion Used Alaway For the Following Reasons

Of those reporting Nasal Congestion, why were they taking Alaway?

Dry Eye
Eye Swelling
Eye Pruritus

Scientific Publications on Nasal Congestion

Powered by Google